durapatite has been researched along with vancomycin in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.92) | 18.2507 |
| 2000's | 11 (21.15) | 29.6817 |
| 2010's | 29 (55.77) | 24.3611 |
| 2020's | 11 (21.15) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, L; Zeng, W | 1 |
| Calhoun, JH; Mader, JT; Shirtliff, ME | 1 |
| Barinov, SM; Hasegawa, M; Komlev, VS; Sudo, A; Uchida, A | 1 |
| Alt, V; Dingeldein, E; Rauschmann, MA; Schnettler, R; Stirnal, V; Wichelhaus, TA; Zichner, L | 1 |
| Kim, HE; Kim, HW; Knowles, JC | 1 |
| Brandt, B; Gosheger, G; Joist, A; Joosten, U; Liljenqvist, U; von Eiff, C | 1 |
| Itokazu, M; Matsumoto, K; Naganawa, T; Shimizu, K; Takigami, I; Uemura, S | 1 |
| Bostrom, M; Gardner, M; Griffith, M; Wanich, T; Zelken, J | 1 |
| Barralet, JE; Gbureck, U; Müller, FA; Vorndran, E | 1 |
| Blanchemain, N; Chai, F; Descamps, M; Hildebrand, HF; Hornez, JC; Neut, C | 1 |
| Chai, F; Descamps, M; Hildebrand, HF; Hornez, JC; Leprêtre, S; Martel, B; Neut, C; Vermet, G | 1 |
| Rauschmann, MA; von Stechow, D | 1 |
| Assor, M | 1 |
| Blanchemain, N; Chai, F; Flament, MP; Hildebrand, HF; Hoang Thi, TH; Leprêtre, S; Martel, B; Siepmann, F; Siepmann, J | 1 |
| Boonen, J; Coenye, T; D'Hondt, M; De Spiegeleer, B; Luyten, J; Mullens, S; Ravelingien, M; Remon, JP; Vervaet, C | 1 |
| Chen, QH; Li, HL; Ma, T; Shang, BC; Tang, H; Xu, GL; Xu, YQ; Zhou, TH | 1 |
| Guo, LH; Guo, YJ; Guo, YP; Ning, CQ; Yao, YB | 1 |
| Dong, J; Fang, TL; Jiang, JL; Li, XL; Li, YF; Wang, YC; Zhou, J | 1 |
| Fan, X; Huang, J; Ma, T; Tang, H; Xu, Y | 1 |
| Kaewsrichan, J; Thanyaphoo, S | 1 |
| Liao, JW; Lin, CC; Yang, CC; Yen, SK | 1 |
| Bostrom, M; Grosso, MJ; Hernandez-Soria, A; Reinhart, J; Ricciardi, BF; Yang, X | 1 |
| Chen, T; Chu, LF; Guo, YJ; Guo, YP; Wang, YY; Wei, YT | 1 |
| Devine, DM; Geever, LM; Higginbotham, CL; Killion, JA | 1 |
| Cai, Y; Chu, X; Tong, P; Yao, J; Yu, J | 1 |
| Cabañas, MV; Lozano, D; Martínez-Vázquez, FJ; Paris, JL; Vallet-Regí, M | 1 |
| Heiss, C; Hess, U; Hill, S; Rezwan, K; Streckbein, P; Treccani, L | 1 |
| Coelho, CC; Monteiro, FJ; Sousa, SR | 1 |
| Cong, Y; Huang, G; Jiang, Q; Liu, J; Liu, M; Quan, C; Tong, G; Yin, Y; Zhang, C | 1 |
| Albayati, ZA; Breen, PJ; Crooks, PA; Karau, MJ; Merten, KE; Morris, AJ; Patel, R; Pierce, WM; Schmidt-Malan, SM; Smeltzer, MS; Steckelberg, JM; Sunkara, M; Taylor, KG | 1 |
| Cao, Z; Jiang, D; Wu, J; Yan, L | 1 |
| Cao, ZD; Jiang, DM; Wu, J; Yan, L | 1 |
| Ballay, R; Braun, M; Chlup, H; Denk, F; Horný, L; Klapková, E; Rýglová, Š; Sucharda, Z; Suchý, T; Šupová, M; Veselý, J; Žaloudková, M | 1 |
| Baino, F; Bollati, D; Cassinelli, C; Iviglia, G; Morra, M; Torre, E; Vitale-Brovarone, C | 1 |
| Bajenaru-Georgescu, D; Demetrescu, I; Ionita, D; Mazare, A; Schmuki, P; Totea, G | 1 |
| Adamková, V; Ballay, R; Denk, F; Horný, L; Hubálek Kalbáčová, M; Klapková, E; Pokorný, M; Průša, R; Rýglová, Š; Sauerová, P; Suchý, T; Šupová, M; Veselý, J; Voňavková, T; Žaloudková, M; Závora, J | 1 |
| Correia, A; Hirvonen, J; Kemell, M; Mäkilä, E; Nadal, E; Salonen, J; Santos, HA; Shahbazi, MA; Shatalin, YV; Zanjanizadeh Ezazi, N | 1 |
| David, N; Nallaiyan, R | 1 |
| Bernstein, A; Faigle, G; Huebner, WD; Mayr, HO; Peters, F; Seidenstuecker, M; Suedkamp, NP | 1 |
| Babaei, M; Ghaee, A; Nourmohammadi, J | 1 |
| Ballay, R; Denk, F; Horný, L; Hubálek Kalbáčová, M; Klapková, E; Pokorný, M; Sauerová, P; Sojka, M; Suchý, T; Šupová, M; Vištejnová, L; Závora, J | 1 |
| Egawa, S; Hirai, K; Matsumoto, R; Okawa, A; Sotome, S; Sugo, K; Yoshii, T; Yuasa, M | 1 |
| Biswas, R; Krishnan, AG; Menon, D; Nair, MB | 1 |
| Aghajani, S; Mansouri Boroujeni, M; Nosrati, H; Zafari, M | 1 |
| Cai, K; Chen, R; Gong, Y; Jia, Y; Qin, L; Yang, W; Yang, Y | 1 |
| Cao, J; Chen, D; He, J; Hu, X; Peng, L; Xiao, J; Xiong, C; Zhang, L; Zhang, Y | 1 |
| Hashimoto, A; Kii, S; Kobatake, T; Mawatari, M; Miyamoto, H; Noda, I; Shobuike, T; Sonohata, M | 1 |
| Alghazali, K; Anderson, DE; Beenken, KE; Biris, AS; Bourdo, SE; Campbell, MJ; Griffin, C; Hecht, S; Jackson, B; King, W; Meeker, DG; Ramirez, AM; Rifkin, R; Smeltzer, MS; Walker, CM | 1 |
| Chai, Y; Dai, H; Huang, K; Mei, Z; Wei, X; Wu, X; Zhang, B | 1 |
| Lv, XF; Sun, XH; Zhao, Z; Zhou, DM | 1 |
| Cheng, X; Peng, C; Ren, G; Wang, Q; Wang, Y; Yuan, B; Zhang, Y; Zhou, S | 1 |
| Cao, S; Du, Y; Huang, H; Kong, W; Lan, H; Li, J; Li, K; Liu, C; Shao, C; Shao, J; Tang, X; Xi, Y; Xu, T; Zhang, G; Zhao, B; Zhao, H | 1 |
1 review(s) available for durapatite and vancomycin
| Article | Year |
|---|---|
[Progress in the study of calcium phosphate cement].
Topics: Animals; Bone Regeneration; Drug Carriers; Durapatite; Humans; Materials Testing; Vancomycin | 1998 |
1 trial(s) available for durapatite and vancomycin
| Article | Year |
|---|---|
Effectiveness of combination use of antibiotic-loaded PerOssal with spinal surgery in patients with spondylodiscitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Calcium Sulfate; Discitis; Drug Therapy, Combination; Durapatite; Female; Gentamicins; Humans; Male; Middle Aged; Nanoparticles; Prospective Studies; Treatment Outcome; Vancomycin | 2009 |
50 other study(ies) available for durapatite and vancomycin
| Article | Year |
|---|---|
Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Colony Count, Microbial; Drug Delivery Systems; Durapatite; Female; Osteomyelitis; Polymethyl Methacrylate; Prostheses and Implants; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tibia; Vancomycin | 2002 |
High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Cephalosporins; Delayed-Action Preparations; Drug Carriers; Durapatite; Female; Femur; Gentamicins; Microscopy, Electron, Scanning; Nanostructures; Porosity; Prostheses and Implants; Rabbits; Vancomycin | 2004 |
Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections.
Topics: Absorbable Implants; Anti-Bacterial Agents; Biocompatible Materials; Calcium Sulfate; Cell Line; Cell Survival; Diffusion; Drug Carriers; Drug Implants; Durapatite; Fibroblasts; Gentamicins; Humans; Materials Testing; Nanostructures; Osteitis; Osteoblasts; Particle Size; Powders; Vancomycin | 2005 |
Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release.
Topics: Anti-Bacterial Agents; Coated Materials, Biocompatible; Compressive Strength; Drug Delivery Systems; Durapatite; Microscopy, Electron, Scanning; Polyesters; Porosity; Tissue Engineering; Vancomycin | 2005 |
Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Topics: Animals; Biological Availability; Body Weight; Bone Cements; C-Reactive Protein; Chronic Disease; Disease Models, Animal; Drug Carriers; Durapatite; Leukocyte Count; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Successful joint arthroplasty after treatment of destructive MRSA arthritis of the knee using antibiotic-loaded hydroxyapatite blocks: a case report.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Biocompatible Materials; Durapatite; Female; Humans; Knee Joint; Methicillin Resistance; Radiography; Staphylococcal Infections; Vancomycin | 2007 |
PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Colony Count, Microbial; Disease Models, Animal; Drug Carriers; Durapatite; Female; Microbial Viability; Osteomyelitis; Polymethacrylic Acids; Radiography; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Tibia; Treatment Outcome; Vancomycin | 2007 |
Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices.
Topics: Adsorption; Anti-Bacterial Agents; Biocompatible Materials; Calcium Phosphates; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Implants; Durapatite; Kinetics; Models, Chemical; Ofloxacin; Polyesters; Polyglycolic Acid; Porosity; Powders; Solubility; Surface Properties; Technology, Pharmaceutical; Temperature; Tetracycline; Vancomycin | 2007 |
Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biocompatible Materials; Ciprofloxacin; Durapatite; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Particle Size; Pilot Projects; Porosity; Staphylococcus aureus; Staphylococcus epidermidis; Surface Properties; Vancomycin | 2007 |
Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymers.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Bone Transplantation; Ciprofloxacin; Cyclodextrins; Drug Delivery Systems; Durapatite; Humans; Kinetics; Mice; Polymers; Staphylococcus aureus; Vancomycin | 2009 |
Noncemented total knee arthroplasty with a local prophylactic anti-infection agent: a prospective series of 135 cases.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Knee; Arthroscopy; Biocompatible Materials; Cefazolin; Debridement; Durapatite; Female; Humans; Knee Prosthesis; Male; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Vancomycin | 2010 |
Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Bacterial Agents; beta-Cyclodextrins; Bone Substitutes; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Delivery Systems; Drug Stability; Durapatite; Gels; Kinetics; Sepharose; Vancomycin | 2010 |
Vancomycin release from poly(D,L-lactic acid) spray-coated hydroxyapatite fibers.
Topics: Anti-Bacterial Agents; Coated Materials, Biocompatible; Drug Delivery Systems; Durapatite; Lactic Acid; Materials Testing; Methicillin-Resistant Staphylococcus aureus; Polyesters; Polymers; Porosity; Vancomycin | 2010 |
Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms.
Topics: Biofilms; Chitosan; Durapatite; Kinetics; Liposomes; Mannans; Nanostructures; Staphylococcus aureus; Vancomycin | 2011 |
Magnetic mesoporous carbonated hydroxyapatite microspheres with hierarchical nanostructure for drug delivery systems.
Topics: Biocompatible Materials; Calcium Carbonate; Drug Carriers; Durapatite; Ferrosoferric Oxide; Magnets; Microscopy, Electron, Scanning; Microspheres; Nanostructures; Porosity; Vancomycin; X-Ray Diffraction | 2011 |
Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Carriers; Drug Implants; Durapatite; Methicillin-Resistant Staphylococcus aureus; Nanostructures; Osteomyelitis; Rabbits; Radiography; Staphylococcal Infections; Tibia; Vancomycin | 2012 |
[Vancomycin cationic liposome combined with nano-hydroxyapatite/chitosan/konjac glucomannan scaffold for treatment of infected bone defects in rabbits].
Topics: Animals; Bone Diseases; Bone Regeneration; Chitosan; Chronic Disease; Durapatite; Liposomes; Mannans; Nanostructures; Osteomyelitis; Rabbits; Staphylococcal Infections; Tissue Scaffolds; Vancomycin | 2012 |
Synthesis and evaluation of novel glass ceramics as drug delivery systems in osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Substitutes; Cell Line; Cell Survival; Ceramics; Drug Delivery Systems; Durapatite; Humans; Osteomyelitis; Rats; Silicon Dioxide; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2012 |
Vancomycin-chitosan composite deposited on post porous hydroxyapatite coated Ti6Al4V implant for drug controlled release.
Topics: Alkaline Phosphatase; Alloys; Animals; Anti-Bacterial Agents; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Durapatite; Femur; Humans; Implants, Experimental; Male; Microbial Sensitivity Tests; Osteoblasts; Osteocalcin; Porosity; Rabbits; Radiography; Staphylococcus aureus; Tibia; Titanium; Vancomycin; X-Ray Diffraction | 2013 |
In vitro elution characteristics of antibiotic laden BoneSource™, hydroxyapatite bone cement.
Topics: Anti-Bacterial Agents; Bone Cements; Durapatite; Tobramycin; Vancomycin | 2013 |
Hollow carbonated hydroxyapatite microspheres with mesoporous structure: hydrothermal fabrication and drug delivery property.
Topics: Calcium Carbonate; Drug Carriers; Durapatite; Microscopy, Electron, Scanning; Microspheres; Nanostructures; Porosity; Vancomycin | 2013 |
Fabrication and in vitro biological evaluation of photopolymerisable hydroxyapatite hydrogel composites for bone regeneration.
Topics: Anti-Infective Agents; Bone Regeneration; Bone Substitutes; Compressive Strength; Dexamethasone; Drug Delivery Systems; Durapatite; Elastic Modulus; Humans; Hydrogels; Infection Control; Materials Testing; Photochemical Processes; Polyethylene Glycols; Spectroscopy, Fourier Transform Infrared; Tissue Engineering; Tissue Scaffolds; Vancomycin | 2014 |
Preparation and characterization of antimicrobial nano-hydroxyapatite composites.
Topics: Anti-Infective Agents; Drug Carriers; Durapatite; Nanoparticles; Staphylococcus aureus; Vancomycin | 2014 |
Fabrication of novel Si-doped hydroxyapatite/gelatine scaffolds by rapid prototyping for drug delivery and bone regeneration.
Topics: Animals; Anti-Bacterial Agents; Bone Regeneration; Cell Line; Cell Proliferation; Drug Delivery Systems; Durapatite; Gelatin; Hydrophobic and Hydrophilic Interactions; Materials Testing; Mice; Microbial Sensitivity Tests; Particle Size; Porosity; Silicon; Spectroscopy, Fourier Transform Infrared; Stress, Mechanical; Sus scrofa; Tissue Scaffolds; Vancomycin; X-Ray Diffraction | 2015 |
A mild one-pot process for synthesising hydroxyapatite/biomolecule bone scaffolds for sustained and controlled antibiotic release.
Topics: Agar; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Bone Substitutes; Cattle; Diffusion; Drug Delivery Systems; Durapatite; Fibrinogen; Gentamicins; Materials Testing; Osteomyelitis; Porosity; Pressure; Serum Albumin; Stress, Mechanical; Tissue Scaffolds; Vancomycin | 2015 |
Heparinized nanohydroxyapatite/collagen granules for controlled release of vancomycin.
Topics: Collagen; Delayed-Action Preparations; Durapatite; Nanoparticles; Staphylococcus aureus; Vancomycin | 2015 |
Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Topics: Alendronate; Animals; Anti-Bacterial Agents; Bone and Bones; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Liberation; Durapatite; Humans; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Micelles; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rats; Vancomycin | 2015 |
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Debridement; Disease Models, Animal; Drug Carriers; Durapatite; Humans; Osteomyelitis; Polyethylene Glycols; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
In vitro and in vivo osteogenic activity of the novel vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) scaffold.
Topics: Animals; Anti-Bacterial Agents; Bone Substitutes; Cell Line; Drug Carriers; Durapatite; Humans; Osteoblasts; Osteogenesis; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds; Vancomycin | 2016 |
Biosafety of the Novel Vancomycin-loaded Bone-like Hydroxyapatite/Poly-amino Acid Bony Scaffold.
Topics: Amino Acids; Animals; Bone and Bones; Durapatite; Microspheres; Polymers; Rabbits; Tissue Scaffolds; Vancomycin | 2016 |
The Sustainable Release of Vancomycin and Its Degradation Products From Nanostructured Collagen/Hydroxyapatite Composite Layers.
Topics: Carbodiimides; Collagen; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Durapatite; Methylamines; Nanoparticles; Nanostructures; Vancomycin | 2016 |
Engineered porous scaffolds for periprosthetic infection prevention.
Topics: Animals; Calcium Phosphates; Cell Line; Chitosan; Delayed-Action Preparations; Durapatite; Implants, Experimental; Mice; Osteoblasts; Pectins; Porosity; Staphylococcal Infections; Staphylococcus epidermidis; Tissue Scaffolds; Vancomycin | 2016 |
Activity of vancomycin release from bioinspired coatings of hydroxyapatite or TiO
Topics: Coated Materials, Biocompatible; Collagen; Drug Liberation; Durapatite; Microbial Sensitivity Tests; Nanotubes; Titanium; Vancomycin | 2017 |
The release kinetics, antimicrobial activity and cytocompatibility of differently prepared collagen/hydroxyapatite/vancomycin layers: Microstructure vs. nanostructure.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Collagen; Drug Delivery Systems; Durapatite; Female; Humans; Male; Nanostructures; Osteoblasts; Plasma; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2017 |
Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Regeneration; Cells, Cultured; Drug Delivery Systems; Durapatite; Electric Conductivity; Gelatin; Mice; Osteoblasts; Polymers; Pyrroles; Silicon Dioxide; Tissue Engineering; Tissue Scaffolds; Vancomycin | 2018 |
Biologically anchored chitosan/gelatin-SrHAP scaffold fabricated on Titanium against chronic osteomyelitis infection.
Topics: Anti-Bacterial Agents; Chronic Disease; Drug Delivery Systems; Drugs, Chinese Herbal; Durapatite; Gelatin; Humans; Mesenchymal Stem Cells; Osteomyelitis; Strontium; Titanium; Vancomycin | 2018 |
Release behavior of VAN from four types of CaP-ceramic granules using various loading methods at two different degrees of acidity.
Topics: Anti-Bacterial Agents; Bone and Bones; Calcium Phosphates; Ceramics; Collagen; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Durapatite; Humans; Hydrogen-Ion Concentration; Kinetics; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Porosity; Temperature; Vancomycin | 2017 |
Poly (sodium 4-styrene sulfonate)-modified hydroxyapatite nanoparticles in zein-based scaffold as a drug carrier for vancomycin.
Topics: Cell Line, Tumor; Compressive Strength; Drug Carriers; Drug Liberation; Durapatite; Elastic Modulus; Humans; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Polystyrenes; Porosity; Spectroscopy, Fourier Transform Infrared; Static Electricity; Surface Properties; Tissue Scaffolds; Vancomycin; Viscosity; Water; Zein | 2019 |
Evaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, gentamicin and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility.
Topics: Anti-Bacterial Agents; Bone Cements; Cell Line; Collagen; Drug Synergism; Durapatite; Enterococcus faecalis; Gentamicins; Humans; Kinetics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prosthesis-Related Infections; Staphylococcus epidermidis; Vancomycin | 2019 |
Efficacy of Antibiotic-Loaded Hydroxyapatite/Collagen Composites Is Dependent on Adsorbability for Treating Staphylococcus aureus Osteomyelitis in Rats.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Bone Regeneration; Cefazolin; Collagen; Drug Evaluation, Preclinical; Drug Implants; Durapatite; Male; Osteomyelitis; Rats, Wistar; Staphylococcal Infections; Vancomycin | 2020 |
Biodegradable nanocomposite fibrous scaffold mediated local delivery of vancomycin for the treatment of MRSA infected experimental osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Drug Delivery Systems; Durapatite; Gelatin; Male; Methicillin-Resistant Staphylococcus aureus; Nanocomposites; Osteomyelitis; Polyesters; Rats, Wistar; Silicon Dioxide; Staphylococcal Infections; Vancomycin | 2020 |
Vancomycin-loaded electrospun polycaprolactone/nano-hydroxyapatite membrane for the treatment of blood infections.
Topics: Durapatite; Humans; Nanofibers; Polyesters; Vancomycin | 2020 |
Experimental and theoretical investigations of the influences of one-dimensional hydroxyapatite nanostructures on cytocompatibility.
Topics: Animals; Animals, Newborn; Calcium; Coated Materials, Biocompatible; Drug Delivery Systems; Drug Liberation; Durapatite; Materials Testing; Nanostructures; Nanotubes; Nanowires; Osteoblasts; Rats; Reactive Oxygen Species; Skull; Spectroscopy, Fourier Transform Infrared; Vancomycin | 2021 |
Chitosan-coated hydroxyapatite and drug-loaded polytrimethylene carbonate/polylactic acid scaffold for enhancing bone regeneration.
Topics: Animals; Biocompatible Materials; Biodegradable Plastics; Bone Regeneration; Cell Adhesion; Cell Line; Chitosan; Dioxanes; Drug Delivery Systems; Drug Liberation; Durapatite; Hydrophobic and Hydrophilic Interactions; Mice; Microspheres; Oleic Acid; Osteoblasts; Osteogenesis; Polyesters; Polymers; Surface Properties; Tissue Engineering; Tissue Scaffolds; Vancomycin | 2021 |
Time-dependent efficacy of combination of silver-containing hydroxyapatite coating and vancomycin on methicillin-resistant Staphylococcus aureus biofilm formation in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Durapatite; Humans; Methicillin-Resistant Staphylococcus aureus; Silver; Staphylococcal Infections; Vancomycin | 2021 |
Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Regeneration; Disease Models, Animal; Drug Delivery Systems; Durapatite; Gentamicins; Osteogenesis; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds; Vancomycin; X-Ray Microtomography | 2021 |
Vancomycin Hydrochloride Loaded Hydroxyapatite Mesoporous Microspheres with Micro/Nano Surface Structure to Increase Osteogenic Differentiation and Antibacterial Ability.
Topics: Anti-Bacterial Agents; Cell Differentiation; Durapatite; Microspheres; Osteogenesis; Vancomycin | 2021 |
Nano Sized Hydroxyapatite-Polylactic Acid-Vancomycin in Alleviation of Chronic Osteomyelitis.
Topics: Animals; Durapatite; Mice; Osteomyelitis; Polyesters; Tissue Scaffolds; Vancomycin | 2022 |
Thermosensitive vancomycin@PLGA-PEG-PLGA/HA hydrogel as an all-in-one treatment for osteomyelitis.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Delayed-Action Preparations; Drug Carriers; Durapatite; Humans; Hydrogels; Micelles; Osteomyelitis; Polyethylene Glycols; Polymers; Spectroscopy, Fourier Transform Infrared; Vancomycin | 2022 |
Dual-Nozzle 3D Printed Nano-Hydroxyapatite Scaffold Loaded with Vancomycin Sustained-Release Microspheres for Enhancing Bone Regeneration.
Topics: Bone Regeneration; Delayed-Action Preparations; Durapatite; Microspheres; Osteogenesis; Polyesters; Printing, Three-Dimensional; Tissue Scaffolds; Vancomycin | 2023 |